IP Library Assignment 024939/0737
Patent Assignment
Reel/Frame 024939/0737

Assignment of Assignor's Interest

Recorded: 2010-09-03 Pages: 3
Assignor
DOW PHARMACEUTICAL SCIENCES
Executed: 2004-01-16
Assignee
NEUROGESX, INC.
2215 BRIDGEPOINTE PARKWAY, SUITE 200, SAN MATEO, CALIFORNIA, 94404
Covered Property (1)
Compositions and Kits for the Removal of Irritating Compounds from Bodily Surfaces
Patent: 8,263,059 →
Application: 12/830,997 →
Publication: US 2010/0269858
Related Assignments (10)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 3, 2010
From: BLEY, KEITH R.; WILCOX, ALLAN L.; JAMIESON, GENE C.; MUHAMMAD, NAWEED
To: NEUROGESX, INC.
Reel/Frame 024939/0772 →
Assignment of Assignor's Interest Sep 3, 2010
From: ANGEL, ARTURO S.; LITLE, LARRY W.
To: DOW PHARMACEUTICAL SCIENCES
Reel/Frame 024939/0704 →
Security Agreement Nov 13, 2012
From: NEUROGESX, INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 029291/0807 →
Assignment and Release of Security Interest Jul 10, 2013
From: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
To: NEUROGESX, INC.
Reel/Frame 030777/0782 →
Assignment of Assignor's Interest Jul 2, 2014
From: NEUROGESX, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 033235/0022 →
Corrective Assignment to Correct the Docket Number Previously Recorded at Reel: 033235 Frame: 0022. Assignor(S) Hereby Confirms the Assignment. Mar 3, 2015
From: NEUROGESX, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 035121/0952 →
Security Interest Jun 10, 2016
From: ACORDA THERAPEUTICS, INC.; CIVITAS THERAPEUTICS, INC.; NEURONEX, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038950/0436 →
Release of Security Interest May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →
Assignment of Assignor's Interest May 22, 2019
From: ACORDA THERAPEUTICS, INC.
To: GRÜNENTHAL GMBH
Reel/Frame 049260/0707 →
Assignment of Assignor's Interest Aug 15, 2019
From: GRÜNENTHAL GMBH
To: AVERITAS PHARMA INC.
Reel/Frame 050065/0189 →